Key Development: United States: Recent Industry Developments August 6, 2025 - Adia Nutrition's subsidiary, Adia Med, entered the $3.9 billion glutathione market by integrating intravenous glutathione therapies into its clinics, complementing stem cell and exosome treatments
By improving liver function and fat transport, and supporting energy production through B12, they can make an active, calorie-controlled lifestyle more effective
This will allow us to determine the correlation of the in vitro results with the actual in vivo responses
We also note that several of the factors recommended are provider-level characteristics, and as such are not feasible to use as a patient characteristic for stratification
Fuller RW, Maxwell DL, Dixon CM, McGregor GP, Barnes VF, Bloom SR, Barnes PJ
Unlock Your Health Revolution